Spin-out seeks to be world leader leveraging microbiome biology's potential

A healthcare and technology investor has joined forces with an intellectual property commercialization company and a genome center to launch a new UK-based company called Microbiotica.

Cambridge Innovation Capital (CIC) and IP Group (LSE: IPO) have announced the creation of the company, which is a spin-out of the UK’s Wellcome Trust Sanger Institute based at the Wellcome Genome Campus in Cambridge.

"The researchers believe that recognition of the importance of the microbiome, the body’s trillions of resident bacteria, represents a paradigm-shift in understanding of its impact on human health and disease"